These rankings are based on data from August 2026
Company
Parallel Bio
Years in business
- 5
Number of employees
- 2-10 employees
Country
- United States
Parallel Bio uses populations of human immune organoids combined with AI to discover and de-risk immunotherapies. Their platform generates proprietary immune data at scale, enabling trial-in-a-dish safety prediction, advanced disease modeling, and target discovery. Verified candidates can be moved to market faster with reduced risk and cost.
API Availability
- Unknown
Pricing
unknown
Use
ai disease diagnosis
target discovery
Position of Parallel Bio on sub rankings
August 2026
Industries
health & sports
it
research & development
Ranking position over time
September 2025 - August 2026
#4,024
Best rank
#13,910
Lowest rank
12-month trend
#13,004
Best rank
#16,540
Lowest rank
12-month trend
#1,671
Best rank
#2,072
Lowest rank
12-month trend
Company
Parallel Bio
Years in business
- 5
Number of employees
- 2-10 employees
Country
- United States
Insights
